Navigation Links
A New Test Developed to Identify Suspected Bowel Cancer Patients

Researchers have announced a new test to identify patients who develop bowel cancer as they have a particular gene that could be at fault is unveiled today//.

An Edinburgh University team conducted the test study, and they presented their report in the New England Journal of Medicine. They explained that the tests would help to make certain that these patients could then get the best treatment and will help identify relatives with the same mutation who might have a great increase in the risk of cancer.

The researchers said that around 20,000 people in the general population are thought to have this exacting class of genetic defect, which is associated with a very high risk of cancer. They explained that the biggest challenge was to identify these people, so as to start preventive measures before the disease kicks in or very early in its stage, so as to have a much higher rates of success in controlling it. It was explained that this study that has been reported was a significant step towards this goal.

The researchers explained that the team had developed the test in a long-term study that involved 870 patients, primarily focusing on the faults in three genes, MLH1, MSH2 and MSH6, which are considered responsible for proteins that help to prevent the DNA damage that are linked with tumour development.

The findings of the team showed that 38, about4% of the patients had faulty genes, almost twice as many as suggested by previous estimates. Prof Malcolm Dunlop, one of the researcher said, 'In the long term, we hope the results of this study will help identify all bowel cancer patients who carry one of these gene faults and then offer tests to their relatives who have not yet developed cancer, so that we can prevent the development of cancer.'

Prof Alex Markham, the chief executive of Cancer Research UK, said: 'These are very valuable findings that will help scientists better understand the process of bowel cancer development, particularly in people who are diagnosed at a young age.'


'"/>




Related medicine news :

1. Scientists Developed Map For Brain Molecular Communities
2. Scientists Developed Cheap Way To Assess Sleep
3. Diabetic Friendly Egg Developed In India
4. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
5. Cervical Cancer Vaccine To Be Developed In India
6. Anti-Microbial Coating For Use Over Biomedical Devices Developed
7. Cure for Osteoarthritis To Be Developed
8. Mice With Human Thought Processes Could Be Developed In The Future
9. Viagra Pill For Women To Be Developed
10. Male Contraceptive Pill Being Developed By Berlin Pharmaceutical
11. New Fertility Predictor Test Developed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... FALLS CHURCH, Va. (PRWEB) , ... February 23, 2017 , ... ... , worries, or problems. He has also continued to spiritually evolve, which is the ... his published book “ Our Spiritual Truths ” (published by Balboa Press) attempts to ...
(Date:2/22/2017)... Los Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... medical detox treatment to the thousands of individuals who have recently fallen victim to ... accredited hospital in Orange County, California, where they are free from the shame, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... accurately understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well ... solution helps transform the HCC Risk Adjustment process from a typical fragmented ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This premier ... absorption from the mouth into the bloodstream. Far outpacing the absorption ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, ... is featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... of neurosurgeons in Michigan performing minimally invasive back surgery that often results in ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... York , February 23, 2017 ... Holter Monitor Market are GE Healthcare, Koninklijke Philips N.V., ... about 48% in the global market in 2015. Strong ... two key factors assessed to be aiding these players ... Research states that the players in the global market ...
(Date:2/23/2017)... Mass. , Feb. 23, 2017   ... partner to global in vitro diagnostics manufacturers and ... series titled "Catalyzing Implementation of NGS-Based Tests" to ... March 30, 2017 at 11am Eastern Standard Time ... is to highlight the need for improved performance ...
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
Breaking Medicine Technology: